Gantrisin® (Sulfisoxazole)-Induced Granulocytopenia

Sulfisoxazole (gantrisin\s=r\),3,4-dimethyl-5-sulfanilamido-isoxazole, introduced in 1946, is widely used in treatment of bacterial infections, especially those of the urinary tract. The drug is said to be one of the safest of the sulfonamides. It is described by the manufacturer as a "single drug\p=m-\not a mixture of several sulfonamides\p=m-\ so that there is less likelihood of sensitization" and as "having greater solubility and higher blood-levels."

show abstract

The Effect of Gantrisin on Prothrombin Activity

Shoemaker

Yow

1954

Journal of Urology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Gantrisin® (Sulfisoxazole)-Induced Granulocytopenia

Cited by 6 publications

References 5 publications

Pharmacology and Toxicology

Pharmacology and Toxicology

THROMBOCYTOPENIC PURPURA INDUCED BY SULFISOXAZOLE (GANTRISIN^®) THERAPY

The Effect of Gantrisin on Prothrombin Activity

Contact Info

Product

Resources

About

Gantrisin® (Sulfisoxazole)-Induced Granulocytopenia

Cited by 6 publications

References 5 publications

Pharmacology and Toxicology

Pharmacology and Toxicology

THROMBOCYTOPENIC PURPURA INDUCED BY SULFISOXAZOLE (GANTRISIN®) THERAPY

The Effect of Gantrisin on Prothrombin Activity

Contact Info

Product

Resources

About

THROMBOCYTOPENIC PURPURA INDUCED BY SULFISOXAZOLE (GANTRISIN^®) THERAPY